GE Vernova Inc vs Nuwellis Inc — how do they compare? GE Vernova Inc trades at $1,024 (market cap $263.90B), while Nuwellis Inc trades at $1.48 (market cap $522.76K). The key difference: GE Vernova Inc is far larger — about 504820.6× Nuwellis Inc's market cap, and GE Vernova Inc pays a 0.2% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| GEV | NUWE | |
|---|---|---|
Market Cap | $263.90B | $522.76K |
Sector | Technology | Technology |
52-Week High | $1.17K | $220.50 |
52-Week Low | $547.96 | $1.42 |
Enterprise Value | $253.57B | -$1.29M |
Dividend Yield | 0.2% | — |
Signals from Pluang's Aura AI — not financial advice
GE Vernova (GEV) trades at $990.32, down 1.0% with bearish technical signals despite strong fundamentals. The company reported impressive Q1 2026 earnings beat but missed Q2 expectations, while maintaining robust profitability with 23.04% net margin and 91.48% ROE. Recent news highlights GEV's $176 billion backlog and positioning in AI-driven power infrastructure demand, though valuation metrics remain elevated with P/E of 28.41 and EV/EBITDA of 84.47.
Outlook remains positive with 75.86% analyst buy ratings and $1,270 consensus price target, representing 28% upside. Key opportunities include AI data center power demand and nuclear energy expansion, while risks include premium valuation sensitivity and execution challenges in managing rapid growth across energy segments.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Latest headlines on both assets
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →